Summary
The effect of hyaluronidase and a combination of hyaluronidase with Adriamycin was investigated on several breast cancer models in vitro and in vivo. In vitro enzyme treatment (using concentrations up to 80 000 IU/l) of murine (MXT−, MXT±, and MXT+) and human (MCF-7, ZR-75-1 and T-47-D) breast cancer cell lines did not inhibit tumour cell proliferation (measured by a kinetic crystal violet assay) in either case. Although highdose hyaluronidase (1.2×106 IU/kg) was ineffective, when administered peritumourally to the MXT M3.2 mammary carcinoma of the B6D2F1 mouse, it is remarkable that five “megadoses” were excellently tolerated. However, the antineoplastic activity of Adriamycin against the oestrogen-receptor-positive variant of the MXT tumour was significantly enhanced by combination with concentrations of hyaluronidase that were inactive per se, both in vitro and in vivo. Interestingly, the enhancement of the in vivo antitumour activity was not compromised by toxic side-effects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Angello JC, Anderson LW, Hosick, HL (1980) Cell surface glycosaminoglycans of tumorigenic and non-tumorigenic mouse mammary epithelial cells. In Vitro 16:210
Angello JC, Hosick HL, Anderson LW (1982) Glycosaminoglycan synthesis by a cell line (C1–S1) established from a preneoplastic mouse mammary outgrowth. Cancer Res 42:4975–4978
Baumgartner G (1987) Hyaluronidase in der Therapie maligner Erkrankungen. Wien Klin Wochenschr [Suppl] 174:1–22
Baumgartner G (ed) 1988 Hyaluronidase-eine wirksame Substanz in der Behandlung maligner Erkrankungen? Referate gehalten im Rahmen der 6. Arbeitstagung des Ludwig Boltzmann-Institutes für Hämatologie und Leukämieforschung, Wien (11. bis 13. Februar 1988). Wien Klin Wochenschr [Suppl] 178:1–23
Baumgartner G, Moritz A (eds) (1988) Hyaluronidase: Anwendung in der Onkologie. Springer-Verlag, Wien Berlin Heidelberg New York
Baumgartner G, Fortelny A, Zänker KS, Kroczek R (1988) Phase I study in chemoresistant loco-regional malignant disease with hyaluronidase. Reg Cancer Treat 1:55–58
Beckenlehner K (1991) Etablierung und Charakterisierung muriner Mammacarcinom-Zellinien (MXT) zur vergleichenden Prüfung neuer Antitumorwirkstoffe. Diplomarbeit, Universität Regensburg
Bernhardt G, Reile H, Birnböck H, Spruß T, Schönenberger H (1992) Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity. J Cancer Res Clin Oncol 118:35–43
Chandrasekaran EV, Davidson E (1979) Glycosaminoglycans of normal and malignant cultured human mammary cells. Cancer Res 39:870–880
Cooper EH, Forbes MA (1988) Serum hyaluronic acid levels in cancer. Br J Cancer 58:668–669
Dahl IM, Laurent TC (1988) Concentration of hyaluronan in the serum of untreated cancer patients with special reference to patients with mesothelioma. Cancer 62:326–330
Dahl IM, Solheim ØP, Erikstein B, Müller E (1989) A longitudinal study of the hyaluronan level in the serum of patients with malignant mesothelioma under treatment. Cancer 64:68–73
Decker M, Chiu ES, Dollbaum C, Moiin A, Hall J, Spendlove R, Longaker MT, Stern R (1989) Hyaluronic acid-stimulating activity in sera from the bovine fetus and from breast cancer patients. Cancer Res 49:3499–3505
Delpech B, Bertrand P, Maingonnat C (1985) Immunoenzymoassay of the hyaluronic acid-hyaluronectin interaction: application to the detection of hyaluronic acid in serum of normal subjects and cancer patients. Anal Biochem 149:555–565
Forrester JV, Wilkinson PC (1981) Inhibition of leukocyte locomotion by hyaluronic acid. J Cell Sci 48:315–331
Frebourg T, Lerebours G, Delpech B, Benhamou D, Bertrand P, Maingonnat C, Boutin C, Nouvet G (1987) Serum hyaluronate in malignant pleural mesothelioma. Cancer 59:2104–2107
Gately CL, Muul LM, Greenwood MA, Papazoglou S, Dick SJ, Kornblith PL, Smith BH, Gately MK (1984) In vitro studies on the cell-mediated immune response to human brain tumors: II. Leukocyte-induced coats of glycosaminoglycan increase the resistance of glioma cells to cellular immune attack. J Immunol 133:3387–3395
Hay, RJ (1988) The seed stock concept and quality control for cell lines. Anal Biochem 171:225–237
Kimata K, Honma Y, Okayama M, Oguri K, Hozumi M, Suzuki S (1983) Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential. Cancer Res 43:1347–1354
Knudson W, Toole BP (1988) Membrane association of the hyaluronate stimulatory factor from LX-1 human lung carcinoma cells. J Cell Biochem 38:165–177
Knudson W, Biswas C, Toole BP (1984a) Stimulation of glycosaminoglycan production in murine tumours. J Cell Biochem 25:183–196
Knudson W, Biswas C, Toole BP (1984b), Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. Proc Natl Acad Sci USA 81:6767–6771
Knudson W, Biswas C, Li XQ, Nemec RE, Toole BP (1989) The role and regulation of tumour-associated hyaluronan. Ciba Found Symp 143:150–169
Kohno N, Ohnuma T, Truog P, Biller H, Holland JF (1988) Effects of hyaluronidase on doxorubicin penetration into multicellular tumour spheroids and cell lethality. Proc Am Assoc Cancer Res 29: abstract no. 1329
Larnier C, Kerneur C, Robert L, Moczar M (1989) Effect of testicular hyaluronidase on hyaluronate synthesis by human skin fibroblasts in culture. Biochim Biophys Acta 1014:145–152
Lehnert M, Liu R, Salmon SE (1989) Hyaluronidase (HYase) enhances drug toxicity on clusters/colonies of P-388 cells in clonogenic assay. Proc Am Assoc Cancer Res 30: abstract no. 2286
Liu R, Cox J, Salmon S (1987) Hyaluronidase enhances the in vitro cytotoxicity of 5-fluorouracil. In Vitro 23: abstract no. 10
Marotta M, Vecchione R, Martino G, D'Armiento FP, De Cesare M, Rosati P (1985) Glycosaminoglycan-enriched extracellular matrix surrounds intraductal carcinoma of human breast: histochemical study. Appl Pathol 3:179–185
Pawlowski A, Haberman HF, Menon IA (1979) The effects of hyaluronidase upon tumor formation in balb/c mice painted with 7,12-dimethylbenz(a)anthracene. Int J Cancer 23:105–109
Pettersson T, Fröscth B, Riska H, Klockars M (1988) Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma. Chest 94:1037–1039
Philipson LH, Westley J, Schwartz N (1985) Effect of hyaluronidase treatment of intact cells on hyaluronate synthetase activity. Biochemistry 24:7899–7906
Prehm P (1990) Release of hyaluronate from eukaryotic cells. Biochem J 267:185–189
Reile H, Birnböck H, Bernhardt G, Spruß T, Schönenberger H (1990) Computerized determination of growth kinetic curves and doubling times from cells in microculture. Anal Biochem 187:262–267
Sargent NSE, Price JE, Tarin D (1983) Effect of enzymatic removal of cell surface constituents on metastatic colonisation potential of mouse mammary tumour cells. Br J Cancer 48:569–577
Scheithauer W, Temsch EM, Stefeneli T, Lathan B (1988) Ergebnisse experimenteller Untersuchungen des zytostatikamodulierenden Effektes von Hyaluronidase bei gastrointestinalen Karzinomzellinien. Wien Klin Wochenschr [Suppl] 178:12–13
Seipelt H, Kohlheb O (1967) Die Mitoseaktivität des Ehrlich-Ascites-Carcinoms der weißen Maus nach intraperitonealen Hyaluronidase-Gaben. Arzneim Forsch 17:513–515
Sokal RR, Rohlf FJ (1987 a) Introduction to biostatistics, 2nd edn. Freeman, New York, p 106
Sokal RR, Rohlf FJ (1987 b) Introduction to biostatistics, 2nd edn. Freeman, New York, p 220
Spruß T, Bernhardt G, Schickaneder E Schönenberger H (1991) Different response of murine and human mammary tumour models to a series of diastereoisomeric [1,2-bis(difluorophenyl)-ethylenediamine]dichloroplatinum(II) complexes. J Cancer Res Clin Oncol 117:435–443
Spruß T, Bernhardt G, Schönenberger H, Engel J (1992) Antitumour activity of miltefosine alone and after combination with platinum complexes on MXT mouse mammary carcinoma models. J Cancer Res Clin Oncol (in press)
Stern M, Longaker MT, Adzick NS, Harrison MR, Stern R (1991) Hyaluronidase levels in urine from Wilms' tumor patients. J Natl Cancer Inst 83:1569–1574
West DC, Kumar S (1989) The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 183:179–196
Wu AH, Parker OS, Ford L (1984) Hyperviscosity caused by hyaluronic acid in serum in a case of Wilms' tumor. Clin Chem 30:914–916
Zänker KS, Trappe A, Blümel G (1982) In-vitro resistance of cloned human glioma cells to natural killer activity of allogeneic peripheral lymphocytes. Br J Cancer 46:617–624
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Wolfgang Wiegrebe on the occasion of his 60th birthday
Rights and permissions
About this article
Cite this article
Beckenlehner, K., Bannke, S., Spruß, T. et al. Hyaluronidase enhances the activity of Adriamycin in breast cancer models in vitro and in vivo. J Cancer Res Clin Oncol 118, 591–596 (1992). https://doi.org/10.1007/BF01211802
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01211802